Wednesday, May 22, 2024

Pfizer’s Lyrica cleared for fibromyalgia

NEW YORK (AP) – Drug developer Pfizer Inc. said Thursday the Food and Drug Administration approved its drug Lyrica as a treatment for fibromyalgia, a widespread and chronic pain condition.

The drug is already approved as a diabetic nerve pain treatment. During the first quarter, Lyrica sales reached $395 million.

Pfizer said about 6 million Americans have fibromyalgia, which is characterized by chronic widespread pain and can cause poor sleep, stiffness and fatigue.

Shares of Pfizer rose 23 cents to close at $25.94.


Questions or comments about this story should be directed to Damian J. Troise at 212-621-7190

Copyright 2007 Associated Press. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

Sam Allcock
Sam Allcock
Sam heads up Cheshire-based PR Fire, an online platform that has already helped over 10,000 businesses to grab widespread media coverage on their news at an extremely accessible price point.

Recent Articles

Related Stories

sakarya escort bayan Eskişehir escort bayan